When
it comes to measuring the value of new treatments, no two therapeutic areas
are alike. Engaging with the right sources of real-world data is critical to
generating actionable insights that support your go-to-market strategy. In
this panel discussion, industry researchers will discuss:
Characteristics they look for in EHR data
Ways RWD contributes to understanding diseases and treatments